Phase 1 OCD Trial, Recruiting NCT07347405 Sponsor: Francisco A Moreno Condition: OCD
Back to Ocd

Phase 1 OCD Trial, Recruiting

NCT07347405
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have been diagnosed with OCD (obsessive-compulsive disorder) based on a structured diagnostic interview
  • Your OCD is at least moderate in severity, based on a standard OCD rating scale score
  • You have tried at least one standard recommended treatment for OCD that did not work well enough
  • You are considered safe to live independently
  • You are willing and able to stop taking certain medications and supplements at least two weeks before the study treatment begins (some medications, such as fluoxetine/Prozac, must be stopped at least six weeks before)

Who may not be able to join:

  • You currently have, or have a history of, a psychosis (a condition involving a break from reality) or an active substance use disorder
  • A close family member (parent, sibling, or child) has a history of psychosis or bipolar disorder
  • You have certain heart conditions, such as a history of stroke or heart attack, uncontrolled high blood pressure, a fast resting heart rate, an abnormal heart rhythm, or a specific type of irregular electrical signal in your heart
  • You have certain metabolic or blood sugar conditions that are not well controlled, including specific diabetes complications
  • You have serious kidney or liver problems
  • You have unstable lung disease (COPD) or severe sleep apnea
  • You have a mental health condition that puts you or others at serious risk, or a personal or close family history of bipolar disorder
  • You regularly take sedatives, narcotic pain medications, or antipsychotic medications
  • You are pregnant, breastfeeding, planning to become pregnant, or planning to donate sperm within three months after the last dose of study medication
  • You or your partner could become pregnant and you are unwilling or unable to use highly effective birth control during the study and for three months after the last dose
  • You have made a suicide attempt in the past 12 months
  • You have any condition that makes it unsafe for you to have an MRI scan, such as a pacemaker, certain metal implants, or certain electrical medical devices in your body
  • You have used recreational drugs (including marijuana, cocaine, opioids, sedatives, or hallucinogens) in the week before your screening appointment
  • You weigh less than 45 kilograms (approximately 99 pounds)
  • You have an allergy or significant intolerance to chocolate or cocoa

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Francisco Moreno, MD, University of Arizona

Phone: (520) 626-8000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Sponsor
Francisco A Moreno
Registry
ClinicalTrials.gov
Start date
18 May 2026
Est. completion
31 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Yale Brown Obsessive Compulsive Scale; Adverse Event (AE) Tracking log; Visual Analogue Scale (VAS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov